Target Name: MIR378G
NCBI ID: G100616321
Review Report on MIR378G Target / Biomarker Content of Review Report on MIR378G Target / Biomarker
MIR378G
Other Name(s): MicroRNA 378g | microRNA 378g | hsa-miR-378g | hsa-mir-378g

MIR378G: A Drug Target / Disease Biomarker

MIR378G, a protein encoded by the gene PPP1A, is a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. MIR378G is a protein that is expressed in various tissues and cells of the body, including the brain, pancreas, and gastrointestinal tract. It is a key regulator of the hematopoietic stem cell (HSC) proliferation and differentiation, and its dysregulation has been implicated in the development and progression of various diseases.

The MIR378G gene is located on chromosome 18q21 and has been implicated in the development of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. MIR378G is a transcription factor that has been shown to promote the expression of genes involved in cell growth, differentiation, and survival. It has been shown to play a role in the regulation of stem cell proliferation and the development of tissues, including the brain.

One of the most promising aspects of MIR378G is its potential as a drug target. MIR378G has been shown to interact with several drug targets, including the and tyrosine kinase (TK) signaling pathway. This interaction suggests that MIR378G may be a useful target for drugs that are currently being developed for the treatment of these diseases.

MIR378G has also been shown to be involved in the regulation of inflammation. It has been shown to play a role in the regulation of the production of pro-inflammatory cytokines, such as TNF-伪 and IL-12, and has been shown to protect against the effects of these cytokines in various cell types. This suggests that MIR378G may be a useful target for drugs that are being developed for the treatment of inflammatory disorders.

MIR378G has also been shown to be involved in the regulation of cell death, and its dysregulation has been implicated in the development of various diseases, including cancer. It has been shown to play a role in the regulation of cell apoptosis, which is a natural mechanism for cell death that helps to remove damaged or dysfunctional cells from the body. MIR378G has also been shown to play a role in the regulation of cell necrosis, which is a form of cell death that is caused by an outside agent, such as exposure to chemotherapy drugs.

In conclusion, MIR378G is a protein that has been shown to play a role in the regulation of various processes in the body, including cell growth, differentiation, and survival. Its dysregulation has been implicated in the development and progression of many diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. As a potential drug target, MIR378G is a promising target for the development of new treatments for these diseases. Further research is needed to fully understand the role of MIR378G in the regulation of various biological processes and to develop effective treatments for the disorders associated with its dysregulation.

Protein Name: MicroRNA 378g

The "MIR378G Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR378G comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR378H | MIR378I | MIR379 | MIR380 | MIR381 | MIR382 | MIR383 | MIR384 | MIR3907 | MIR3908 | MIR3909 | MIR3910-1 | MIR3910-2 | MIR3911 | MIR3912 | MIR3913-1 | MIR3913-2 | MIR3914-1 | MIR3914-2 | MIR3915 | MIR3916 | MIR3917 | MIR3918 | MIR3919 | MIR3920 | MIR3921 | MIR3922 | MIR3923 | MIR3924 | MIR3925 | MIR3926-1 | MIR3926-2 | MIR3927 | MIR3928 | MIR3929 | MIR3934 | MIR3935 | MIR3936 | MIR3936HG | MIR3937 | MIR3938 | MIR3939 | MIR3940 | MIR3941 | MIR3942 | MIR3943 | MIR3944 | MIR3945 | MIR3945HG | MIR3960 | MIR3972 | MIR3973 | MIR3974 | MIR3976 | MIR3976HG | MIR3977 | MIR3978 | MIR409 | MIR410 | MIR411 | MIR412 | MIR421 | MIR422A | MIR423 | MIR424 | MIR425 | MIR4251 | MIR4252 | MIR4253 | MIR4254 | MIR4255 | MIR4256 | MIR4257 | MIR4258 | MIR4259 | MIR4260 | MIR4261 | MIR4262 | MIR4263 | MIR4264 | MIR4265 | MIR4266 | MIR4267 | MIR4268 | MIR4269 | MIR4270 | MIR4271 | MIR4272 | MIR4273 | MIR4274 | MIR4275 | MIR4276 | MIR4277 | MIR4278 | MIR4279 | MIR4280 | MIR4281 | MIR4282 | MIR4283-1 | MIR4283-2